These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 24157364

  • 21. Tetanus Toxin cis-Loop Contributes to Light-Chain Translocation.
    Zuverink M, Bluma M, Barbieri JT.
    mSphere; 2020 May 06; 5(3):. PubMed ID: 32376703
    [Abstract] [Full Text] [Related]

  • 22. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
    Davies JR, Liu SM, Acharya KR.
    Toxins (Basel); 2018 Oct 20; 10(10):. PubMed ID: 30347838
    [Abstract] [Full Text] [Related]

  • 23. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.
    Yao G, Lam KH, Perry K, Weisemann J, Rummel A, Jin R.
    Toxins (Basel); 2017 Mar 08; 9(3):. PubMed ID: 28282873
    [Abstract] [Full Text] [Related]

  • 24. Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.
    Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A, Bodeker MO, Gilmore MA, Fernández-Salas E, Francis J, Steward LE, Aoki KR, Dolly JO.
    J Biol Chem; 2008 Jun 20; 283(25):16993-7002. PubMed ID: 18400760
    [Abstract] [Full Text] [Related]

  • 25. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y, Singh BR.
    Protein Expr Purif; 2004 Mar 20; 34(1):8-16. PubMed ID: 14766296
    [Abstract] [Full Text] [Related]

  • 26. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
    Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S.
    J Mol Biol; 2009 Feb 13; 386(1):233-45. PubMed ID: 19118561
    [Abstract] [Full Text] [Related]

  • 27. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW, Chai Q, Christian T, Stevens RC.
    Biochemistry; 2006 Mar 14; 45(10):3255-62. PubMed ID: 16519520
    [Abstract] [Full Text] [Related]

  • 28. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa.
    Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA.
    J Biol Chem; 1996 Mar 29; 271(13):7694-9. PubMed ID: 8631808
    [Abstract] [Full Text] [Related]

  • 29. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
    Kohda T, Ihara H, Seto Y, Tsutsuki H, Mukamoto M, Kozaki S.
    Microb Pathog; 2007 Mar 29; 42(2-3):72-9. PubMed ID: 17188834
    [Abstract] [Full Text] [Related]

  • 30. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 31. Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.
    Ahnert-Hilger G, Münster-Wandowski A, Höltje M.
    Curr Top Microbiol Immunol; 2013 Mar 20; 364():159-77. PubMed ID: 23239353
    [Abstract] [Full Text] [Related]

  • 32. Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons.
    Meng J, Wang J, Lawrence GW, Dolly JO.
    FASEB J; 2013 Aug 20; 27(8):3167-80. PubMed ID: 23640057
    [Abstract] [Full Text] [Related]

  • 33. [Botulinum neurotoxin].
    Poulain B.
    Rev Neurol (Paris); 2010 Jan 20; 166(1):7-20. PubMed ID: 19846187
    [Abstract] [Full Text] [Related]

  • 34. Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.
    Chellappan G, Kumar R, Santos E, Goyal D, Cai S, Singh BR.
    Biochim Biophys Acta; 2015 Oct 20; 1854(10 Pt A):1510-6. PubMed ID: 26012869
    [Abstract] [Full Text] [Related]

  • 35. A protein chip membrane-capture assay for botulinum neurotoxin activity.
    Marconi S, Ferracci G, Berthomieu M, Kozaki S, Miquelis R, Boucraut J, Seagar M, Lévêque C.
    Toxicol Appl Pharmacol; 2008 Dec 15; 233(3):439-46. PubMed ID: 18845174
    [Abstract] [Full Text] [Related]

  • 36. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
    Hackett G, Moore K, Burgin D, Hornby F, Gray B, Elliott M, Mir I, Beard M.
    Toxins (Basel); 2018 May 11; 10(5):. PubMed ID: 29751611
    [Abstract] [Full Text] [Related]

  • 37. Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.
    Fischer A, Montal M.
    Toxicon; 2013 Dec 01; 75():101-7. PubMed ID: 23396042
    [Abstract] [Full Text] [Related]

  • 38. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.
    Potter KJ, Bevins MA, Vassilieva EV, Chiruvolu VR, Smith T, Smith LA, Meagher MM.
    Protein Expr Purif; 1998 Aug 01; 13(3):357-65. PubMed ID: 9693060
    [Abstract] [Full Text] [Related]

  • 39. The Translocation Domain of Botulinum Neurotoxin A Moderates the Propensity of the Catalytic Domain to Interact with Membranes at Acidic pH.
    Araye A, Goudet A, Barbier J, Pichard S, Baron B, England P, Pérez J, Zinn-Justin S, Chenal A, Gillet D.
    PLoS One; 2016 Aug 01; 11(4):e0153401. PubMed ID: 27070312
    [Abstract] [Full Text] [Related]

  • 40. Characterization of Clostridium sp. RKD producing botulinum-like neurotoxin.
    Dixit A, Dhaked RK, Alam SI, Singh L.
    Syst Appl Microbiol; 2005 Jul 01; 28(5):405-14. PubMed ID: 16094867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.